BSG LIVE ’26 · LEX Liverpool · 22–25 June 2026
Meet Our Team – Heading to BSG Liverpool
In June 22nd, Calpro will be at BSG LIVE ’26 in Liverpool – one of the UK’s most important gatherings for gastroenterology and IBD care. We’re sending two of our very best. Before you make it to the stand, we want to introduce them – and give you a sense of what we’ll be talking about.
BSG LIVE ’26
Meet our UK team – in their own words
Rachel Clough
Country Manager (UK)
Rachel brings a deep understanding of IBD diagnostics across the full care pathway – from laboratory procurement to clinical adoption. She is the person to talk to if you want to understand how Calpro’s broader portfolio fits your service, your team, and your patients.
What does Calpro mean to you?
“It’s 30 years of calprotectin expertise packed into solutions that work in the real world – whether that’s the lab, the clinic, or the patient’s home.”
What are you most excited to show at BSG LIVE?
“The full portfolio story. People often know us for one product, but seeing how CalproLab, Easy Extract, and CalproSmart connect across the care pathway – that’s where it clicks.”
Who should come find you?
“Lab managers, gastro nurses, anyone involved in IBD diagnostics procurement – and honestly, anyone curious about where calprotectin testing is heading.”
Simon Hall
Key Account Manager (UK)
Simon works closely with clinicians and IBD teams across the UK, supporting the implementation of calprotectin testing in both point-of-care and remote monitoring settings. His focus is on making CalproSmart work in the real world – from clinical workflow integration to patient pathway design.
What does Calpro mean to you?
“Calpro gives clinicians the tools to act on what matters – early, accurately, and without putting patients through unnecessary procedures.”
What are you most excited to show at BSG LIVE?
“CalproSmart is a real conversation-starter. Seeing a clinician use it for the first time and realise how fast it is – that reaction never gets old.”
Who should come find you?
“Anyone managing IBD patients who wants to reduce the burden on their endoscopy lists. If you’re thinking about remote monitoring, let’s talk.”
Who we are
The Calprotectin Company – 30+ years of focused expertise
Calpro is a Norwegian biotechnology company with one singular focus: calprotectin. For more than three decades, we have developed, manufactured, and distributed clinically validated calprotectin solutions that help clinicians and patients make timely, confident decisions in IBD care.
Calprotectin is the leading non-invasive biomarker for intestinal inflammation – recommended by ECCO, NICE, and AGA guidelines. It differentiates IBD from IBS, enables sub-clinical detection of flare, and supports real-time mucosal healing assessment. Our portfolio is built around this biomarker, from laboratory ELISA assays to point-of-care and home monitoring solutions.
Hospitals, laboratories, clinicians, and patients across Europe trust Calpro to support early detection of inflammation and effective monitoring of disease progression throughout the IBD care pathway.
Our portfolio highlights
Two flagship solutions – and a complete care pathway
Also in our portfolio: CalproLab® ELISA and RUO kits for high-precision laboratory testing, and Calpro Easy Extract® – a hygienic, standardised stool sample preparation device that works across our entire test range.
Book a meeting!
Or simply drop by the Calpro stand for a live chat!
Leave a Reply